David A. Zarling

City:

Menlo Park, California

Country:

United States

Published Applications:

Last publication date:

2013-12-19

Top Assignees for applications by David A. Zarling

The entities that hold a legal rights for patent applications filed by inventor Zarling David A.:

COLBY PHARMACEUTICAL COMPANY 3 Menlo Park, CA United States
Medical College of Wisconsin Inc. 1 Milwaukee, WI United States
INVITROGEN CORPORATION 1 Carlsbad, CA United States

Recent patent applications by Zarling David A.

David A. Zarling from Menlo Park, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2013-12-19

US20130338110A1

Chemistry; metallurgy

MITOCHONDRIA TARGETED CATIONIC ANTI-OXIDANT COMPOUNDS FOR PREVENTION, THERAPY OR TREATMENT OF HYPER-PROLIFERATIVE DISEASE, NEOPLASIAS AND CANCERS

#2 | 2013-08-15

US20130210772A1

Chemistry; metallurgy

Androgen induced oxidative stress inhibitors

#3 | 2011-03-10

US20110059922A1

Chemistry; metallurgy

Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers

#4 | 2010-11-25

US20100297262A1

Human necessities

PHARMACEUTICALLY ACTIVE COMPOSITIONS COMPRISING OXIDATIVE STRESS MODULATORS (OSM), NEW CHEMICAL ENTITIES, COMPOSITIONS AND USES

#5 | 2006-10-12

US20060228799A1

Chemistry; metallurgy

Use of consensus sequences for targeted homologous gene isolation and recombination in gene families

#6 | 2005-12-20

US9557423

Locked nucleic acid hybrids and methods of use

#7 | 2005-09-29

US20050214944A1

Human necessities

In vivo homologous sequence targeting in cells

InventorID:

391066 ⎘